(Q33772175)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10558038%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

review article

1 reference

title

A review of quality-of-life evaluations in patients with congestive heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10558038%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

0 references

1 reference

congestive heart failure

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10558038%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

C Berry

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10558038%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10558038%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10558038%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10558038%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10558038%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

247-271

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10558038%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00019053-199916030-00003

1 November 2019

exact match

0 references

cites work

Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups

1 reference

12 December 2020

Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. V-HeFT II. The V-HeFT VA Cooperative Studies Group

1 reference

12 December 2020

Measuring quality of life in medicine.

1 reference

12 December 2020

Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group

1 reference

12 December 2020

Development and testing of a new measure of health status for clinical trials in heart failure

1 reference

12 December 2020

Role of surrogate end points in the evaluation of drugs for heart failure

1 reference

12 December 2020

Analysis of quality of life data from a randomized, placebo-controlled heart-failure trial

1 reference

12 December 2020

Utility approach to measuring health-related quality of life

1 reference

12 December 2020

A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure

1 reference

12 December 2020

Measuring disease-specific quality of life in clinical trials

1 reference

12 December 2020

Development and testing of the UK SF-12 (short form health survey).

1 reference

12 December 2020

Quality of life in cancer patients--an hypothesis

1 reference

12 December 2020

Comparison of the effects of cilazapril and captopril versus placebo on exercise testing in chronic heart failure patients: a double-blind, randomized, multicenter trial. The Cilazapril-Captopril Multicenter Group

1 reference

12 December 2020

The quality of life, research, and care

1 reference

12 December 2020

1 reference

12 December 2020

Quality of life in women with heart failure.

1 reference

12 December 2020

Usefulness of bucindolol in congestive heart failure

1 reference

12 December 2020

Gender differences in 1-year survival and quality of life among patients admitted with congestive heart failure

1 reference

12 December 2020

Quality of life: can it and should it be assessed in patients with heart failure?

1 reference

12 December 2020

Improved quality of life in chronic heart failure patients following local endurance training with leg muscles.

1 reference

12 December 2020

Treadmill exercise in assessment of the functional capacity of patients with cardiac disease

1 reference

12 December 2020

Methodologic assessments of quality of life measures in clinical trials

1 reference

12 December 2020

Effects of 12 weeks of ramipril treatment on the quality of life in patients with moderate congestive heart failure: results of a placebo-controlled trial. Ramipril Study Group

1 reference

12 December 2020

Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study

1 reference

12 December 2020

Does encouraging good compliance improve patients' clinical condition in heart failure?

1 reference

12 December 2020

The Nottingham Health Profile--a measure of health-related quality of life

1 reference

12 December 2020

Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy

1 reference

12 December 2020

Relationships between general health measured with the sickness impact profile and respiratory symptoms, physiological measures, and mood in patients with chronic airflow limitation

1 reference

12 December 2020

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

Methodologic problems in clinical trials in heart failure

1 reference

12 December 2020

Effect sizes for interpreting changes in health status.

1 reference

12 December 2020

STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

1 reference

12 December 2020

Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies of Left Ventricular Dysfunction. The SOLVD Investigators.

1 reference

12 December 2020

Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators.

1 reference

12 December 2020

Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group

1 reference

12 December 2020

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

12 December 2020

Self-assessed disability in patients with arthrosis of the hip joint. Reliability of the Swedish version of the Nottingham Health Profile.

1 reference

12 December 2020

Improved ventilation and decreased sympathetic stress in chronic heart failure patients following local endurance training with leg muscles.

1 reference

12 December 2020

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

12 December 2020

Quality of life in early heart failure. The study of men born in 1913

1 reference

12 December 2020

Assessing the quality of life of patients in cancer clinical trials: Common problems and common sense solutions

1 reference

12 December 2020

Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Health status, quality of life, and the individual.

1 reference

12 December 2020

Chronic heart failure and quality of life: the impact of nursing

1 reference

12 December 2020

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

12 December 2020

The sickness impact profile: conceptual formulation and methodology for the development of a health status measure

1 reference

12 December 2020

Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 Study Group.

1 reference

12 December 2020

Predicting future functional status for seriously ill hospitalized adults. The SUPPORT prognostic model

1 reference

12 December 2020

Comparison of Quality of Well-Being scale and NYHA functional status classification in patients with atrial fibrillation. New York Heart Association

1 reference

12 December 2020

Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).

1 reference

12 December 2020

Measurement of quality of life in clinical trials of therapy

1 reference

12 December 2020

Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems. Results from the Medical Outcomes Study.

1 reference

12 December 2020

Circulatory status and response to cardiac rehabilitation in patients with heart failure

1 reference

12 December 2020

Measurement of clinical efficacy in studies of heart failure.

1 reference

12 December 2020

Quality of life with ACE inhibitors in chronic heart failure

1 reference

12 December 2020

The placebo effect in heart failure

1 reference

12 December 2020

A randomized controlled trial of inspiratory muscle training in stable chronic heart failure

1 reference

12 December 2020

Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence.

1 reference

12 December 2020

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group

1 reference

12 December 2020

Beta blockers in heart failure: a comparison of a vasodilating beta blocker with metoprolol

1 reference

12 December 2020

Quality of life in chronic heart failure: cilazapril and captopril versus placebo. Cilazapril-Captopril Multicentre Group

1 reference

12 December 2020

Vasodilation by urapidil in the treatment of chronic congestive heart failure in addition to angiotensin-converting enzyme inhibitors is not beneficial: results of a placebo-controlled, double-blind study.

1 reference

12 December 2020

A quantitative approach to perceived health status: a validation study

1 reference

12 December 2020

Quality of life on enalapril after acute myocardial infarction.

1 reference

12 December 2020

Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study

1 reference

12 December 2020

Effects of enoximone on quality of life

1 reference

12 December 2020

Quality of life as an outcome measure

1 reference

12 December 2020

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

1 reference

12 December 2020

Survival after the onset of congestive heart failure in Framingham Heart Study subjects

1 reference

12 December 2020

Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators

1 reference

12 December 2020

Health status of heart transplant recipients versus patients awaiting heart transplantation: a preliminary evaluation of the SF-36 questionnaire.

1 reference

12 December 2020

Quality of life on angina therapy: a randomised controlled trial of transdermal glyceryl trinitrate against placebo

1 reference

12 December 2020

Measurement of the quality of life in congestive heart failure-Influence of drug therapy

1 reference

12 December 2020

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

1 reference

12 December 2020

Congestive heart failure. Towards a comprehensive treatment

1 reference

12 December 2020

A shorter form health survey: can the SF-12 replicate results from the SF-36 in longitudinal studies?

1 reference

12 December 2020

The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS?

1 reference

12 December 2020

The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors.

1 reference

12 December 2020

Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group

1 reference

12 December 2020

Determinants of perceived health in patients with left ventricular dysfunction: a structural modeling analysis.

1 reference

12 December 2020

Effect of drug treatment on quality of life in mild to moderate heart failure

1 reference

12 December 2020

Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale

1 reference

12 December 2020

Quality of life in heart failure treated with enoximone

1 reference

12 December 2020

Quality-adjusted life-years. Ethical implications for physicians and policymakers

1 reference

12 December 2020

Measurement of health-related quality of life in heart failure

1 reference

12 December 2020

Skeletal muscle endurance training improves peripheral oxidative capacity, exercise tolerance, and health-related quality of life in women with chronic congestive heart failure secondary to either ischemic cardiomyopathy or idiopathic dilated cardio

1 reference

12 December 2020

Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death.

1 reference

12 December 2020

Symptoms and tests of ventricular performance in the evaluation of chronic heart failure

1 reference

12 December 2020

Generic versus disease-specific health status measures. An example using coronary artery disease and congestive heart failure patients.

1 reference

12 December 2020

Self-assessment of quality of life in severe heart failure. An instrument for clinical use

1 reference

12 December 2020

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

12 December 2020

Quality of life measurement for patients with diseases of the airways

1 reference

12 December 2020

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

12 December 2020

Interday reliability of function assessment for a health status measure. The Quality of Well-Being scale.

1 reference

12 December 2020

Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group

1 reference

12 December 2020

Health status: types of validity and the index of well-being

1 reference

12 December 2020

Reporting on quality of life in randomised controlled trials: bibliographic study

1 reference

12 December 2020

Short form 36 (SF36) health survey questionnaire: normative data for adults of working age

1 reference

12 December 2020

Validating the SF-36 health survey questionnaire: new outcome measure for primary care

1 reference

12 December 2020

A controlled trial of digoxin in congestive heart failure

1 reference

12 December 2020

Quality of life in cardiovascular disease

1 reference

12 December 2020

A critical appraisal of the quality of quality-of-life measurements

1 reference

12 December 2020

Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group

1 reference

12 December 2020

Comparison of effects on peak oxygen consumption, quality of life, and neurohormones of felodipine and enalapril in patients with congestive heart failure.

1 reference

12 December 2020

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

12 December 2020

Symptomatic improvement and reduced hospitalization for patients attending a cardiomyopathy clinic.

1 reference

12 December 2020

Quality of life on treatment with metoprolol in dilated cardiomyopathy: results from the MDC trial. Metoprolol in Dilated Cardiomyopathy trial.

1 reference

12 December 2020

A comparison of three quality of life instruments in subjects with angina pectoris: the Sickness Impact Profile, the Nottingham Health Profile, and the Quality of Well Being Scale.

1 reference

12 December 2020

Evaluation of treatment for congestive heart failure in patients aged 60 years and older using generic measures of health status (SF-36 and COOP charts).

1 reference

12 December 2020

Assessment of quality of life

1 reference

12 December 2020

Exercise-based rehabilitation improves skeletal muscle capacity, exercise tolerance, and quality of life in both women and men with chronic heart failure.

1 reference

12 December 2020

Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo

1 reference

12 December 2020

Burden and outcomes of hospitalisation for congestive heart failure

1 reference

12 December 2020

Perceived health: age and sex comparisons in a community

1 reference

12 December 2020

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.

1 reference

12 December 2020

The effect of hypotensive drugs on the quality of life.

1 reference

12 December 2020